Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    15801322 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Urban Environmental Factors and Childhood Asthma
Conditions: Asthma;   Allergy
2 Completed ICATA Asthma Mechanistic Study
Condition: Asthma
Intervention: Biological: Omalizumab
3 Completed
Has Results
Inner-City Anti-IgE Therapy for Asthma
Condition: Asthma
Interventions: Biological: omalizumab;   Biological: omalizumab placebo

Indicates status has not been verified in more than two years